Ligand Pharmaceuticals (LGND)

Add to Watchlists
Create an Alert
64.13 +1.23  +1.96% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
LGND Price Chart
View All Events

LGND Events

Date Type Description
Mar 11 Misc Ligand Announces Highlights From Presentation at the 26th Annual Roth Capital Conference
Feb 11 Misc Q4 2013 Ligand Conference Call
Feb 11 Earnings Q4 2013 Ligand Earnings Results. Estimate: 0.20.
Nov 14 Misc Ligand Pharmaceuticals Incorporated Analyst Day
Nov 14 Misc Ligand Pharmaceuticals Incorporated (Nasdaq:lgnd) Will Host an Analyst Day on Thursday, November 14, 2013 From 9:30 a.m. To 11:30 a.m. Central Time ( 7:30 a.m. To 9:30 a.m. Pacific Time ) in Chicago at the Drake Hotel , 140 East Walton Place . The Ev
Oct 30 Misc Ligand Announces Third Quarter 2013 Call
Oct 30 Earnings Ligand to Report Third Quarter Results on October 30th. Estimate: 0.06.
Oct 14 Misc Ligand to Host Analyst Day on November 14th in Chicago
Aug 01 Earnings Ligand to Report Second Quarter Results on August 1st. Estimate: 0.05.
Aug 01 Misc Q2 2013 Earnings Conference Call
View All Performance Charts

LGND Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Ligand Pharmaceuticals is up 160.4% over the last year vs S&P 500 Total Return up 23.54%, Metabasis Therapeutics up 20.00%, and Alexion Pharmaceuticals up 58.10%.

Get Quote for

PDF Report for LGND

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download LGND Pro Report PDF

Portfolio Strategies Featuring LGND

Did Ligand Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

LGND Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Ligand Pharmaceuticals, Inc. is a biotechnology company that operates with a business model focused on developing or acquiring assets. It is engaged in development and commercialization of drugs using Captisol technology by CyDex Pharmaceuticals, Inc.

Recent Quotes

Symbol Price Chg Chg % Market Cap
LGND 64.13 +1.23 +1.96% 1.313B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.